Back to top
more

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$237.84 USD

237.84
1,032,669

+0.54 (0.23%)

Updated Jul 29, 2024 04:00 PM ET

After-Market: $237.77 -0.07 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

OPKO's BioReference Laboratories Offers COVID-19 Testing

OPKO's (OPK) BioReference Laboratories will initially provide testing for facilities at Burlington, Essex, Hudson, Ocean and Union Counties in New Jersey.

The Zacks Analyst Blog Highlights: Roche, Thermo Fisher Scientific, Becton, Dickinson and Teladoc Health

The Zacks Analyst Blog Highlights: Roche, Thermo Fisher Scientific, Becton, Dickinson and Teladoc Health

Trina Mukherjee headshot

4 Potential Gainers Amid Intensifying Coronavirus Fears

Amid the pandemonium associated with coronavirus, we look into four stocks that have the potential to benefit from this outbreak.

BD (BDX) & BioGX Submit EUA to Speed Up Coronavirus Screening

BD (BDX) expects screening to ramp up by 1,000 per day once authorized.

BD MAX Gets CE Mark for Coronavirus Detection, Shares Up

BD (BDX) and Spain's CerTest Biotec collaborate to detect the COVID-19 in Europe.

Trina Mukherjee headshot

Coronavirus-Affected MedTech Drags S&P 500 Index Down

Amid uncertainty surrounding the coronavirus outbreak, here are a few S&P 500 MedTech stocks that took a hit.

Becton Dickinson (BDX) Down 5.2% Since Last Earnings Report: Can It Rebound?

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sriparna Ghosal headshot

3 MedTech Stocks to Rebound After Coronavirus-Led Recoil

As the coronavirus chaos continues to rise, MedTech firms have been witnessing a spike in demand for protective respiratory equipment.

PDCO or BDX: Which Is the Better Value Stock Right Now?

PDCO vs. BDX: Which Stock Is the Better Value Option?

Aparajita Dutta headshot

Coronavirus Spreads Rapidly Worldwide: Medtech Stocks in Focus

The coronavirus outbreak disrupts manufacturing and supply chain in China, which in turn might have taken a toll on U.S. Medtech stocks.

Sreyoshi Mukherjee headshot

Bleak Outlook for Medical Dental Supplies Industry

Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.

New Strong Sell Stocks for February 13th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Becton, Dickinson (BDX) Q1 Earnings Beat, Revenues Rise Y/Y

Becton, Dickinson (BDX) sees softness in BD Medical unit, slashes FY20 view.

Becton Dickinson (BDX) Tops Q1 Earnings and Revenue Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 0.76% and 1.23%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Medical Products Stock Feb 6 Earnings Roster: BDX, CAH & More

Despite the ongoing US-China trade war, increased focus on innovation is likely to have driven performance of medical products players' quarterly performance.

BD Life Sciences to Aid Becton, Dickinson (BDX) Q1 Earnings

BD's (BDX) core Life Sciences arm is expected to have driven first-quarter performance.

Analysts Estimate Becton Dickinson (BDX) to Report a Decline in Earnings: What to Look Out for

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Becton Dickinson (BDX) Keep the Earnings Surprise Streak Alive?

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Hold on to Becton, Dickinson Stock Now

Becton, Dickinson (BDX) expects fiscal 2020 revenue growth to be driven by recent product launches.

The Zacks Analyst Blog Highlights: Royal Dutch, TOTAL, Becton, Dickinson, Workday and TransDigm

The Zacks Analyst Blog Highlights: Royal Dutch, TOTAL, Becton, Dickinson, Workday and TransDigm

Mark Vickery headshot

Top Research Reports for Royal Dutch Shell, TOTAL & Becton, Dickinson

Today's Research Daily features new research reports on 16 major stocks, including Royal Dutch Shell (RDS.A), TOTAL (TOT) and Becton, Dickinson (BDX).

Becton Dickinson (BDX) Up 2.6% Since Last Earnings Report: Can It Continue?

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold on to Becton, Dickinson Stock Now

Becton, Dickinson (BDX) expects tariffs to impact its bottom line in first-quarter fiscal 2020.

BD's Onclarity HPV PMA Submission to Boost Women's Health

Becton, Dickinson (BDX) offers a wide range of next-generation solutions in the field of cervical, ovarian and breast cancer.

Becton, Dickinson (BDX) Beats on Q4 Earnings and Revenues

Becton, Dickinson (BDX) gains from solid segmental contributions in Q4.